Skip to main content
Caplight Logo









Aenitis Technologies

Aenitis Technologies

Private
ParisHealthcare & Life Scienceshttps://www.aenitis.fr/

Last Round

VC Round

Oct 10, 2024

Total Funding Raised

$10.44M

Company Overview

Aenitis Technologies is a biotechnology company that develops and markets acoustofluidic technology for contact-free cell handling, sorting, and filtration to make cell and gene therapy manufacturing safer and less expensive.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

acoustofluidicscell processingacoustophoresisbioprocessingcell therapy manufacturingacoustic cell manipulationlab-on-a-chipbiomanufacturingGMP bioprocessingmicrofluidicsmodular type packageMTPcontract development and manufacturing organizationCDMOsingle-use consumablesbiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aenitis Technologies Comparables

Compare Aenitis Technologies with similar companies based on industry and business-model similarity.

Aenitis Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ascent Bio-Nano Technologies
83%
AcouSort AB
82%
LevitasBio
77%

Aenitis Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 10, 2024
GrantDec 10, 2019
GrantDec 11, 2018
Series AAug 19, 2018
GrantNov 30, 2017
Seed
Oct 19, 2016

Key People

Founding team and executive leadership

Emmanuel VINCENT

Chief Executive Officer

Executive Team

Emmanuel VINCENT-BALLEREAU

CEO

Executive Team

Aenitis Technologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2025

    Signed a Memorandum of Understanding (MOU) with the global pharmaceutical company.

  • Oct 10, 2024

    $7M round led by European Innovation Council and Seventure Partners.

Aenitis Technologies Filings

Explore SEC and related filing metadata, where available.

Aenitis Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aenitis Technologies's valuation, stock price, and market status.

Is Aenitis Technologies a public or private company?

Aenitis Technologies is a private company.

What is the current stock price of Aenitis Technologies?

Aenitis Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is Aenitis Technologies worth (valuation)?

Valuation information for Aenitis Technologies is not publicly available.

Can I buy Aenitis Technologies stock?

Aenitis Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aenitis Technologies's last funding round?

Aenitis Technologies's most recent funding round was Series A on October 10, 2024.

Who are the main investors in Aenitis Technologies?

Key investors in Aenitis Technologies include European Innovation Council, Seventure Partners.

Will Aenitis Technologies IPO soon?

No public IPO plans have been announced for Aenitis Technologies.

How can I track Aenitis Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aenitis Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range14
Year Founded2014
Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?